2 most recent filings and news items mentioning BNGO. Updated every 60 seconds.
LeadershipJun 24, 2026Positive
Bionano Genomics announced the hiring of Alex Hastie, Ph.D., as Chief Scientific Officer, effective July 20, 2026. His return signals a strategic focus on advancing optical genome mapping and research applications in oncology.
View filing at SEC.gov →
RestructuringMay 28, 2026Positive
Bionano Genomics fully retired all outstanding Senior Secured Convertible Debentures using cash on hand, eliminating all secured debt obligations and asset liens. The move removes financial constraints and provides greater operational flexibility for the company to focus on comme
View filing at SEC.gov →
AI-summarized public filings for informational purposes only. Not investment advice. Always verify against the original filing at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.